Form 8-K - Current report:
SEC Accession No. 0001564590-22-007611
Filing Date
2022-02-28
Accepted
2022-02-28 16:06:14
Documents
13
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20220228.htm   iXBRL 8-K 46038
2 EX-99.1 fgen-ex991_6.htm EX-99.1 364010
  Complete submission text file 0001564590-22-007611.txt   552935

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20220228.xsd EX-101.SCH 5693
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20220228_lab.xml EX-101.LAB 18687
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20220228_pre.xml EX-101.PRE 11127
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20220228_htm.xml XML 3402
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 22689339
SIC: 2834 Pharmaceutical Preparations